OOIR: Observatory of International Research

Papers

(The H4-Index of Microbial Biotechnology is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Issue Information	132
Issue Information	102
	85
Corrigendum	83
Modulation of yeast Erg1 expression and terbinafine susceptibility by iron bioavailability	78
Biotechnological production optimization of argyrins – a potent immunomodulatory natural product class	73
The future of Microbial Biotechnology	67
Use of non‐canonical amino acids in genetic code expansion‐based therapeutics: Effects on mouse gut microbiota	63
Co‐substrate composition is critical for enrichment of functional key species and for process efficiency during biogas production from cattle manure	62
Unravelling the role of the group 6 soluble di‐iron monooxygenase (SDIMO) SmoABCD in alkane metabolism and chlorinated alkane degradation	56
Cultivating complexity: Advancements in establishing in vitro models for the mucus‐adhering gut microbiota	53
Rhodopsin‐based light‐harvesting system for sustainable synthetic biology	53
Combined Isotopic Tracer and Modelling Approach Reveals Differences in Nitrogen Metabolism in S. cerevisiae, S. uvarum and S. kudriavzevii Species	52
Harnessing the Ecological and Genomic Adaptability of the Bacterial Genus Massilia for Environmental and Industrial Applications	52
Journals Operating Predatory Practices Are Systematically Eroding the Science Ethos: A Gate and Code Strategy to Minimise Their Operating Space and Restore Research Best Practice	51
Characterisation and Harnessing of 5‐Hydroxymethylfurfural Metabolism in Pseudomonas umsongensis GO16 for the Production of 2,5‐Furandicarboxylic Acid	47
Massive integration of large gene libraries in the chromosome of Escherichia coli	46
Controlled production of lipopolysaccharides increases immune activation in Salmonella treatments of cancer	46
Baogong decoction treats endometritis in mice by regulating uterine microbiota structure and metabolites	43
Bringing up to date the toolkit for the catabolism of aromatic compounds in fungi: The unexpected 1,2,3,5‐tetrahydroxybenzene central pathway	43
Proton motive force and antibiotic tolerance in bacteria	41
Electrified bioreactors: the next power‐up for biometallurgical wastewater treatment	40
Production of biofuels from C₁‐gases with Clostridium and related bacteria—Recent advances	38
Patent landscape analysis—Contributing to the identification of technology trends and informing research and innovation funding policy	38
Can bioplastics always offer a truly sustainable alternative to fossil‐based plastics?	38

Development of a live biotherapeutic throat spray with lactobacilli targeting respiratory viral infections	37
Hyperproduction of PHA copolymers containing high fractions of 4‐hydroxybutyrate (4HB) by outer membrane‐defected Halomonas bluephagenesis grown in bioreactors	37
Recent advances in producing food additive L‐malate: Chassis, substrate, pathway, fermentation regulation and application	37
Marinobacter: A case study in bioelectrochemical chassis evaluation	37
	37
(Poly)phosphate biotechnology: Envisaged contributions to a sustainable P future	36
How can we possibly resolve the planet's nitrogen dilemma?	36
Reduced Genetic Heterogeneity for Stable Bioproduction by Harnessing the Bias and Mechanism of Mutation	36
This is the Age of Microbial Technology: Crucial roles of learned societies and academies	35
Hindrance to sustainable development: Global inequities, non‐progressive education and inadequate science‐policy dialogue	35